Woodline Partners LP Bristol Myers Squibb CO Transaction History

Woodline Partners LP

  • $19.5 Billion
  • Q3 2025

A detailed history of Woodline Partners LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Woodline Partners LP holds 990,251 shares of BMY stock, worth $46.4 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
990,251
Previous 976,360 1.42%
Holding current value
$46.4 Million
Previous $45.2 Million 1.18%
% of portfolio
0.23%
Previous 0.26%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$43.31 - $48.98 $601,619 - $680,381
13,891 Added 1.42%
990,251 $44.7 Million
Q2 2025

Aug 14, 2025
SELL
$44.12 - $59.6 $13.9 Million - $18.8 Million
-315,255 Reduced 24.41%
976,360 $45.2 Million
Q1 2025

May 15, 2025
SELL
$53.9 - $63.11 $14.6 Million - $17 Million
-270,007 Reduced 17.29%
1,291,615 $78.8 Million
Q4 2024

Feb 14, 2025
BUY
$51.92 - $59.94 $40.7 Million - $47 Million
783,466 Added 100.68%
1,561,622 $88.3 Million
Q3 2024

Nov 14, 2024
BUY
$39.66 - $51.75 $594,265 - $775,422
14,984 Added 1.96%
778,156 $40.3 Million
Q2 2024

Aug 14, 2024
SELL
$40.25 - $52.99 $244,800 - $322,285
-6,082 Reduced 0.79%
763,172 $31.7 Million
Q1 2024

May 15, 2024
BUY
$47.98 - $54.4 $7,484 - $8,486
156 Added 0.02%
769,254 $41.7 Million
Q4 2023

Feb 14, 2024
BUY
$48.48 - $57.85 $25.8 Million - $30.8 Million
531,618 Added 223.86%
769,098 $39.5 Million
Q3 2023

Nov 14, 2023
BUY
$57.89 - $64.73 $2.16 Million - $2.41 Million
37,280 Added 18.62%
237,480 $13.8 Million
Q2 2023

Aug 14, 2023
SELL
$63.71 - $70.74 $3.91 Million - $4.34 Million
-61,413 Reduced 23.47%
200,200 $12.8 Million
Q1 2023

May 15, 2023
BUY
$65.71 - $74.53 $193,384 - $219,341
2,943 Added 1.14%
261,613 $18.1 Million
Q4 2022

Feb 14, 2023
SELL
$68.48 - $81.09 $632,070 - $748,460
-9,230 Reduced 3.45%
258,670 $18.6 Million
Q3 2022

Nov 14, 2022
SELL
$0.13 - $76.84 $75,696 - $44.7 Million
-582,280 Reduced 68.49%
267,900 $19 Million
Q2 2022

Aug 15, 2022
BUY
$72.62 - $79.98 $33 Million - $36.4 Million
454,610 Added 114.93%
850,180 $65.5 Million
Q2 2021

Aug 16, 2021
SELL
$61.91 - $67.42 $13.1 Million - $14.2 Million
-211,261 Reduced 34.81%
395,570 $26.4 Million
Q1 2021

May 17, 2021
BUY
$59.34 - $66.74 $36 Million - $40.5 Million
606,831 New
606,831 $38.3 Million
Q4 2020

Feb 16, 2021
SELL
$57.74 - $65.43 $63.7 Million - $72.2 Million
-1,103,742 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$57.43 - $63.64 $63.4 Million - $70.2 Million
1,103,742 New
1,103,742 $66.5 Million
Q1 2020

May 15, 2020
SELL
$46.4 - $67.43 $25.7 Million - $37.3 Million
-552,945 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$49.21 - $64.19 $27.2 Million - $35.5 Million
552,945 New
552,945 $35.5 Million

Others Institutions Holding BMY

# of Institutions
2,684
Shares Held
1.58B
Call Options Held
28M
Put Options Held
28.4M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email